6 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... Diabetes #Diabetic #Medications ... #Pharmacology #Dosing ... #Dosing #Renal ... Impairment #CKD #Table
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... GLP-1 receptor agonists ... #diabetes #medications ... #table #comparison
Summary of Pharmacology for Select Proposed COVID-19 Treatments

#Pharmacology #Dosing #Table #COVID19 #Coronavirus #SARSCOV2 #Medications #JAMA
Summary of Pharmacology ... #Pharmacology #Dosing ... #Table #COVID19 ... #Coronavirus #SARSCOV2 ... #Medications #JAMA
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
Dosing: 3 mg ... semaglutide, the same medication ... oral route by using ... drug to remain stable ... take any other medications
Summary of actions of some Cholinergic Agonists

Bethanechol 
• Used in treatment of urinary retention 
• Binds
Summary of actions ... some Cholinergic Agonists ... Produces miosis during ... #Pharmacology #Table ... #Summary
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Cardiomyopathy - Summary ... Management during ... Management during ... Delivery • Stable ... Bromocriptine, a dopamine agonist